Roche: The Hanover specialty growth to rebound after moderating to 3.4% in Q3

Published: Fri 1 Nov 2024

The Hanover’s CEO has expressed confidence that growth in his company’s specialty business will rebound in the fourth quarter after moderating in Q3 because of profitability improvement initiatives in its programs segment.